Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BTOG 2020 | Neuroendocrine morphology

Denis Talbot • 30 Jan 2020
BTOG 2020
General

Denis Talbot, BSc, MB, BChir, MA, PhD, FRCP, University of Oxford, Oxford, UK, outlines a UK nationwide cohort study he co-authored that investigated the impact of neuroendocrine morphology on cancer outcomes and stage at diagnosis. This interview took place at the 18th British Thoracic Oncology Group (BTOG) 2020 congress held in Dublin, UK.

More from Denis Talbot

2:03
Early diagnosis: clinical implications
Denis Talbot • 30 Jan 2020
2:33
Lung Cancer: post-frontline immunotherapy
Denis Talbot • 31 Jan 2020
1:24
Denis Talbot: lifetime achievement award winner
Denis Talbot • 30 Jan 2020

Related Videos

0:29
Innovative ctDNA-based liquid biopsy techniques for cancer diagnosis
Alain Thierry • 9 Apr 2024
0:50
Employing fragmentomics as a novel strategy to characterize and detect cancers
Alain Thierry • 9 Apr 2024
1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
3:10
PALOMA: subcutaneous amivantamab in advanced solid tumors
Natasha Leighl • 17 Apr 2024
The content of VJOncology is intended for healthcare professionals